Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

DAT (DOAC+clopidogrel)

Preclinical

CChonnam National University Hospital

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Myocardial Infarction (MI)Recruiting

Myocardial Infarction (MI)Preclinical

Recruiting

Timeline

Expected Milestones

Q4 2032

PreclinicalRecruiting

Myocardial Infarction (MI)

NCT07583784

Clinical

Trials by Indication[1]

Myocardial Infarction (MI)1 trial

Heart-team for Evidence-based RevascularizatiOn: Abbreviated Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Acute Myocardial Infarction

Recruiting·CChonnam National University Hospital·Preclinical·NCT07583784·860 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for DAT (DOAC+clopidogrel). U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for DAT (DOAC+clopidogrel). EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Chonnam National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: CChonnam National University Hospital

Related News